Island Pharmaceuticals Ltd (ILA) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of Island Pharmaceuticals Ltd stock A$0.16, price A$0.28, that is 44.0% below the price, quality 28 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Island Pharmaceuticals Ltd
ILA · AUFar too expensive (fair value 44% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range A$0.0530 – A$0.5700 · fair‑value band A$0.1175 – A$0.1959 · the A$0.2800 price screens above the A$0.1567 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Island Pharmaceuticals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for antiviral therapeutics in Australia and the United States of America.
Show moreShow less
Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. Island Pharmaceuticals Limited was founded in 2017 and is based in Hawthorn East, Australia.
Stock analysis
Island Pharmaceuticals Ltd (ILA) currently trades at A$0.2800, while our estimate is A$0.1567, 44% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: A$0.1175 (bear) to A$0.1959 (bull), the price of A$0.2800 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 28/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Island Pharmaceuticals Ltd reported revenue of A$283K in FY2025 versus A$0 in FY2021. Reported net income was −A$9.8M in FY2025.
Key figures
Market cap A$82.9M (≈ $55.2M) Micro · EPS (TTM) A$−0.0400 · Return on equity −95.5% · Return on assets (EBIT) −109% (5-year average) · Operating margin −2,240% · Revenue (TTM) A$283K · Revenue growth (YoY) +996% · Free cash flow −A$4.8M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 9 out of 100 (medium confidence).
What moves the price
The share trades about 51% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at −44%, ILA screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare Island Pharmaceuticals Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 850 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/B ratio by industry
- Net margin by industry
- Piotroski F-Score screener with fair value
- Valuation of the Australia market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $923.34 | $1,275 | +38% | vs ILA |
| Vertex Pharmaceuticals Incorporated VRTX | $520.66 | $587.62 | +13% | vs ILA |
| Samsung Biologics Co 207940 | 1,375,000 KRW | 1,512,500 KRW | +10% | vs ILA |
| argenx SE ARGX | $942.04 | $908.40 | −4% | vs ILA |
| CSL Limited CSL | A$197.29 | A$186.49 | −5% | vs ILA |
| BeOne Medicines AG 6160 | HK$242.60 | HK$152.92 | −37% | vs ILA |
| Moderna, Inc MRNA | $199.33 | $122.98 | −38% | vs ILA |
| Revolution Medicines, Inc RVMD | $159.43 | $83.12 | −48% | vs ILA |
| Celltrion, Inc 068270 | 215,000 KRW | 74,574 KRW | −65% | vs ILA |
| Royalty Pharma plc RPRX | $67.72 | $19.01 | −72% | vs ILA |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Island Pharmaceuticals Ltd (ILA) overvalued or undervalued?
What is the fair value of ILA?
What is the quality score of ILA?
What is the price target for Island Pharmaceuticals Ltd (ILA)?
What is the Island Pharmaceuticals Ltd stock forecast for 2026?
What is the revenue of Island Pharmaceuticals Ltd (ILA)?
What is the intrinsic value of Island Pharmaceuticals Ltd (ILA)?
Is Island Pharmaceuticals Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of ILA?
How much is Island Pharmaceuticals Ltd worth?
What do the bullish and bearish scenarios say about ILA?
How solid is the balance sheet of Island Pharmaceuticals Ltd (ILA)?
How far is ILA from its 52-week high?
Which stocks are comparable to Island Pharmaceuticals Ltd?
Is Island Pharmaceuticals Ltd stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Island Pharmaceuticals Ltd (ILA)?
What should I pay attention to with Island Pharmaceuticals Ltd right now?
Key figures of Island Pharmaceuticals Ltd
How large is the market capitalisation of Island Pharmaceuticals Ltd (ILA)?
What are the earnings per share of Island Pharmaceuticals Ltd (ILA)?
What is the return on equity of Island Pharmaceuticals Ltd (ILA)?
What is the EBIT return on assets of Island Pharmaceuticals Ltd (ILA)?
What is the operating margin of Island Pharmaceuticals Ltd (ILA)?
How fast is revenue growing at Island Pharmaceuticals Ltd (ILA)?
How much free cash flow does Island Pharmaceuticals Ltd (ILA) generate?
How much net cash does Island Pharmaceuticals Ltd (ILA) hold?
Watch Island Pharmaceuticals Ltd in the live analysis
One click puts Island Pharmaceuticals Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.